Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The European Commission is proposing to restrict the sowing of seed treated with the fungicide, metalaxyl-M, to greenhouses.
Bayer's Crop Science division has suspended sales of its fungicidal seed treatment, Monceren (pencycuron), in the EU with immediate effect.
The US microbial products company, BioConsortia (Davis, California), has moved a biostimulant seed treatment to the registration phase.
BASF has introduced the fungicidal seed treatment, Ilevo (fluopyram), in Australia. It is for the control of blackleg (Leptosphaeria maculans) on canola.
The US-based, UK-listed bioproducts company, Plant Health Care (PHC – Raleigh, North Carolina), is applying to register via a "fast track" route for its lead Innatus 3G peptide compound, PHC279, as a seed treatment in Brazil for Asian soybean rust (Phakopsora pachyrhizi).
The US EPA has proposed the approval of Bayer legacy company Monsanto's biopesticide plant growth regulator, LCO (lipochitooligosaccharide) MOR116.
Nufarm has received approval for its bionematicidal seed treatment, Trunemco (cis-jasmone + Bacillus amyloliquefaciens strain MBI 600), in 28 US states following federal EPA registration in May.
EuropaBio, the European Association for Bioindustries, has been a vocal opponent of EU efforts to regulate gene-edited crops in the same way as ‘traditional’ genetically modified (GM) crops.
Bayer's Crop Science division presented new seed treatments at last week’s World Seed Congress hosted by the International Seed Federation, in Nice, France.
Bayer’s Crop Science division has unveiled its insecticidal/fungicidal seed treatment, Chucaro (prothioconazole + clothianidin + fluoxastrobin + tebuconazole), for use on cereals.
The US EPA has approved Nufarm’s bionematicidal seed treatment, Trunemco (cis-jasmone + Bacillus amyloliquefaciens strain MBI 600).
The US EPA has proposed the approval of Nufarm's bionematicidal seed treatment, Trunemco (cis-jasmone + Bacillus amyloliquefaciens strain MBI 600).
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.